NITRO IV Drug Patent Profile
✉ Email this page to a colleague
When do Nitro Iv patents expire, and when can generic versions of Nitro Iv launch?
Nitro Iv is a drug marketed by Pohl Boskamp and is included in one NDA.
The generic ingredient in NITRO IV is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitro Iv
A generic version of NITRO IV was approved as nitroglycerin by AM REGENT on May 24th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NITRO IV?
- What are the global sales for NITRO IV?
- What is Average Wholesale Price for NITRO IV?
Summary for NITRO IV
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 3,066 |
| DailyMed Link: | NITRO IV at DailyMed |
US Patents and Regulatory Information for NITRO IV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pohl Boskamp | NITRO IV | nitroglycerin | INJECTABLE;INJECTION | 018672-002 | Aug 30, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
